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Background: Brain injury often occurs not only primary brain injury, but often also occur secondary
brain injury. Inflammation is a process that occurs immediately after trauma characterized by
activation of the mediator substance. TNF-c is a major cytokinee involved in the inflammatory
processes that have adverse effects ifthe serum level are excessive. There needs to be a balance ofthe
inflammatory process in the brain injury so things that harm does not occur. As anti-inflammatory lL-
l0 plays an important role in maintaining the balance. The objective ofthis study is to determine the
eflect of lL-10 intervention as an anti-inflammatory will decrease the serum level of TNF-c in
traumatic brain injury. Material And Method: Experimental Study in the Rattus Wistar rats, post
test control group Cesign, male, aged 34 months, with body weight (BW) 300-4009, were obrained
from the Laboratory Animal Faculty of Medicine, University of Hasanuddin as much as 24 tails,
which is the result of breeding. Subjecs were divided into four groups, each group of six rats, treated
with conrolled cortical impact model (Feeney's weighfdrop) of traumatic brain injury. Blood taken
with capillary tube in retro-orbita plexus or sinus.This study has approved by ethical clearance for
research. Results: Levels of TNF-a group of rats I hour post-trauma without administration of
recombinant IL-10 (28.58 + 7.28) pg / mL; was significantly higher (p <0.05) than the levels ofTNF-
o rats without kaniektomi group (22.06 * 3.34) pg / mL and group kraniektomi rats without brain
injury (23.07 + 2.51)pgl mL. Levels ofTNF-C group ofrats I hour post-trauma by administration of
recornbinant IL-l0 (23.39 + 6.30)pglmL; significantly lower (p <0.05) than the group of rats I hour
post-trauma without administration ofrecombinant IL-10; and did not different significantly (p> 0.05)
in the group without craniectomy or craniectomy group without head injury. Conclusions:
Intervention of recombinant IL-I0 decreases levels ofTNF-o serum soon after traumatic brain iniuw
in rats.
Keywords: TNF-c; IL-10; traumatic; brain; injury.
INTRODUCTION
Tumor Necrosis Factor (TNF-0) is another
cytokinee that has a role in TBI. TNF-o mRNA and
protein increased in the initial period after TBI trial
and before the infiltration of leukocytes showed that
the initial source of production of TNF-0 is a
collection ofthe Cell. lncreased levels ofTNF-q was
also observed clinically in patients with TBI. TNF-0
is a proinflammatory that are similar to IL-l and
exacerbate inflammation and secondary brain
damage after TBl. Early up regulation by TNF-o
neurons after TBI was found to conlribute to the
subsequent neurological dysfunction.'
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In the inflammalory response, endothelial cell
adhesion molecule triggers for leukocytes, including
E-selectin, intracellular adhesion moleculel (ICAM-
l) and vascular cell adhesion moleculel (VCAM-l).
The combination of the release of chemokines
(including IL-8, MCP-I and IP-10), this response
facilitates the binding of different populations of
leukoc)'les fiee on antigen recognition. In addition,
many special features of inflammation that can be
produced through local effects of TNF on
endothelial cells. TNF triggers the expression of
cyclooxygenase-2 in order to trigger the production
of PGI2 vasodilatori which produces vasodilation,
causing rubor and heat through increased blood flow
around. This is a new concept in which two double
role of TNF is a proinflammatory mediators as well
as dangerous cytokine an in vitro data base neutoxik.
And in vivo data showed neuro protective by
pharmacological inhibition models neuro inflamasi
and neuro degeneration.2 Cytokine detected in
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primary brain produced by lymphocytes and
monocytes infiltrating active nerve system. In the
media injuries, particularly TNFo increased at
lhour, 4 hours reaching a maximum level at 1.4
times that of the control. In ischemic culture media,
TNF-a did not change betweenl to 2 hours. then
increased at 4 h, the maximuml evel of 2. 2 times the
control value with value of 8 hours.2 Cytokinees are
protein hormones that mediate a wide class of
inflammatory and immune r€sponses are complex,
sensitive way relation ship. Major cytokinees that
play a role in response to trauma, including tumor
necrosis factor-alpha (TNF-o), interleukin-l beta
0L-lp), lL-2, 1L-6, IL-8, IL-4 and IL-I8 course. In
other words, the cytokinee IL-10 counter the effects
of pro-inflammatory cytokinees IL-I, IL-6 and TNF-
o in diverse contexts.' Such as IL-lp, TNF-o is
considered as pure pro inflammatory cytokinees in
the short termin TBI research. TNF-g release time
out side consistent in experimental paradigm focal
TBI in rats (closed cortex damage, fluid percussion,
or stab wounds), by detecting the level of I hour
post-damage, the maximum concentration of 3-8
hours, and a decrease in there lease of 24 hours in
the brain. Similarly, TNF-o, IL-6 shows the role of
the neuro-inflammation was detected in I hour post-
injury in animals, followed by the peak
concentrations between 2 to 8 hours. lntra thecal
production facts on anti-inflammatory cytokinee IL-
l0 increased in acute within 24 hours of damage,
associated with a decrease in TNF-o. In addition,
Transforming growth factor-pl (TGF-BI) increased
in CSF serum on I day and 3 weeks post-damage.
Interestingly, serum levels of IL-10 is increased in
severe brain injury, such as polytrauma patients,
potentially bringing this cytokineeas a marker non
specific TBI as prevalent mechanism in response to
damage to TBI.a
Cytokine has become the focus of scientific
interest for more than a decade now. The scientific
analyzes the expression better understanding of the
pathogenesis of various diseases. In addition, they
ar€ now beyond the level when their interest to study
the pathophysiology; some cytokinee therapy is
ready to use from the clinical practice, ranging from
initial exploration well established test the therapists
who are ready to be proven.'
Mosman and scientists first described that
cytokinees produced by T helper cell2 (Th2) and
Th2 cells that inhibit the formation of interferon
[FN). Cytokinee synthesis inhibiting factor (CSIF)
is known as interleukin 0L-10).'
MATERIALS AND METHODS
Rattus Wistar, male, aged 3-4 months, with
body weight (BW) 300-4009 were obtained from the
Laboratory Animal Faculty of Medicine, University
of Hasanuddin as much as 24 tails. which is the
result of breeding. Subjects were divided into four
groups, each group of six rats, randomly selected,
that is without CT =without traumatic brain injury
and craniectomy / normal rats (TNF-a check) CT
without TBI : normal rats performed a craniectomy,
without traumatic brain injury treated (TNF-a
check), CT+TBI (1 Hour) : Group performed a
craniectomy and given a traumatic brain injury
(TNF-a checkl hour post-treatment) CT+TBI+Rec
IL-10 (l Hour) = Group performed a craniectomy
was given a traumatic brain injury and immediately
give the intervention of recombinant IL-10 (check
TNF-a I hour post-heatment).
Rats then adapted to the new environment for I
week before the study is done. Animals kept in a
cage made of a material that is water proofi
robustand easy to clean, with an area of80-100 cm 2
and a height of 14-15 cm. Acclimatization animal
made 7 days prior to the study.
After a midline skin incision, a 5-7 mm
craniectomy was made from 3 mm right posterior of
the bregma and 2 mm right lateral to the midline.
The animals were then subjected to TBI using a
small iron bar, receiving a contact velocity of 571.17
Newtor/mm'. Cylindrical tube 25 cm long, 5 mm in
diameter, directing the iron ball weighing 2.5 g to
obtain 571.17 newtons / mm2 with the calculation of
the I : 2 I 5mr2 (I = force, m : mass, r = distance)
dropped to the top areas have been already
craniectomy. Cylindrical tubes are kept to a 90-
degree angle using iron ball and spaced one inch
from the surface of the rat brain to maintain the
compressed air. Recombinant IL-10 treated mice at a
dose of 20 mg / kg.'
Data were analyzed by SPSS. Applied data
normality test TNF-o serum Shapiro-Wilk test. Data
showed TNF in each group of data are normally
distributed. To assess the levels of TNF-q
comparison between groups use One Way Anova
followed by LSD (least significant defference).
Limit the use of significance o = 57o.
RESULTS
The comparison serum levels of TNF-u By Group
Tablel
The comparison serum levels of TNF-a By Group
6 23.07 (2.5Db
28.58 (7.28)'
23.3e (6.30f
Variable Group Test statistic
Level CT
TNF-c CT
( pglml) without
TBI
CT+TBI(l Hour)
CT+TBI+
Rec IL-
l0 (l
Hour)
6
6
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CT= craniectomy; TBI= Traumatik Brain Injury;
Rec=rekombinan. The same super scriptin the same
column indicatep > 0.05(not significant), and if
different shows p<0.05 (significant). This data
analized with One Way Anova + LSD;
Table I shows that the group of rats with brain
injury treatment had higher levels of serum TNF-o
were significantly higher (p<0.05) than the control
(group without CT and CT groups); I hour after
treatment of brain injury. Group who suffered a
brain injury and was given recombinant IL-10 did
not have elevated levels of TNF-q in serum after I
hour after brain injury; significant difference
(p<0.05) with a group of rats with brain injury
without being given recombinant IL-10; and did not
differ significantly (p>0.05) with the two control
groups.
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Figure I
Graph enor bars serum levels of TNF-a by groups
of rats
From Figure I it can be seen that the serum levels of
TNF-o was higher in the group of rats treated brain
injury an hour earlier. Rats fed a brain injury and
was given the commission of recombinant IL-10;
one hour after brain injury have serum levels of
TNF-o in common with the two control groups.
Craniectomy can increase the levels of TNF-c.
Groups of rats with brain injury treatment had
higher levels of serum TNF-c were significantly
higher (p<0.05) than the control (group without
craniectomy and craniectomy group). Group who
suffered a brain injury and was given recombinant[-10 did not have elevated levels of TNF-o in
serum after I hour after brain injury, a different
meaning to the group who suffered a brain injury
without being given recombinant IL-10'
From the results of the above table shows that
craniectomy actions can increase the levels of TNF-
a significantly, any intervention that causes injury
to body tissues can increase the levels of TNF-c, a
proinflammatory cytokinee that is dominant and not
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specific to brain tissue damage alone. Increased
levels of TNF-q was highest in the early trauma or
the first hour. Shows the pro-inflammatory response
occurs shortly after a traumatic brain injury,
administration of recombinant IL-10 can reduce
levels of TNF-a significantly in the first hour.
The accumulation of leukocytes in traumatic
brain injury causes leukocytes migrate out of the
blood vessels into the brain parenchyma injury by
binding to endothelia lP-selectin and intercellular
adhesion molecule E and (ICAMs). Leukocyte cell
will produce T lymphocytes and B lymphocytes' T
lymphocytes, consisting of cell Th-l and Th-2 cells.
Th-l cells secrete IFN-Y, TNF-c, IL-2. IFN-Y is
what works activates macrophages and induces
MHC-II. Macrophages will also produce IL-12
which serves to stimulate the production of IFN-Y,
TNF-o, andlL-2. TNF-o will increase inflammation
in endothelial cells. 7'E
Provision of recombinant IL-10 as an anti-
inflammatory role big enough in lowering serum
levels of TNFo and work quickly immediately after
the first hour of administration. Provision of
recombinant IL-10 can increase production ofIL-10
itself by TIn.7'8
At the same time when there is inflammation,
Th-2 cells will produce IL-l0, IL-5, and IL-4. IL-10
is an inhibitor of macrophages and dendritic cells,
which play a role in the control of non-specific
immune response and cellular immune. In dendritic
cells, lL-10 will prevent the production of IL-I2 and
expressing kostimulator and MHC-II. By
administering recombinant IL-10, it will inhibit the
activation of macrophages and inhibit the activation
of Thl by blocking lL-12 in producing TNFo."o
CONCLUSIONS
Based on the research results it can be
concluded that administration of IL-10, reduce
levels of TNFc serum immediately after traumatic
brain injury in rats (p<0.05).
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